Abstracts Archive - Page 2081 of 2607 - ACR Meeting Abstracts

Abstract Number: 2303 • 2014 ACR/ARHP Annual Meeting
Clinical Observation on Ankylosing Spondylitis Patients with Different Phenotypes
Zhiming Lin¹, Jun Qi², Jieruo Gu³ and Pingping Zhang⁴, ¹The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, ²The Third Affiliated Hospital of Sun Yat-sen University, guangzhou, China, ³Rheumatology, The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, ⁴Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Background/Purpose :Juvenile and adult forms of ankylosing spondylitis (AS) have been shown different in initial symptoms,clinical presentation ,imaging manifestations and prognosis.So,according to the diagnostic criteria…
Abstract Number: 2304 • 2014 ACR/ARHP Annual Meeting
Positive HLA-B27 in Juvenile Spondyloarthritis Is Associated to Early Sacroiliitis and Progression to Ankylosing Spondylitis
Mariana O Perez¹, Nadia E Aikawa¹, Solange Carrasco¹, Percival D Sampaio-Barros², Celio R. Gonçalves², Carla G.S. Saad², Julio C. B. Moraes² and Cláudia Goldeinstein-Schainberg², ¹University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Juvenile spondyloarthritis (JSpA) manifests with axial and peripheral involvement, enthesitis and HLAB27+ in 60-90% children. Radiological sacroiliitis may occur within 10 years, representing an…
Abstract Number: 2305 • 2014 ACR/ARHP Annual Meeting
Improving Screening for Hyperlipidemia in Patients with Rheumatoid Arthritis at an Academic Rheumatology Practice
Ashwini Komarla¹ and Alexis Ogdie², ¹Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA
Background/Purpose Cardiovascular disease is the leading cause of mortality in the rheumatoid arthritis (RA) population. However, cardiovascular risk factors such as hyperlipidemia are undertreated in…
Abstract Number: 2306 • 2014 ACR/ARHP Annual Meeting
Quality of Care for Cardiovascular Prevention in RA: Compliance with Diabetes Screening Guidelines
Timothy J Schmidt^1,2, J Antonio Avina-Zubieta^2,3,4, Eric C. Sayre³, Michal Abrahamowicz⁵, John M. Esdaile^2,6,7 and Diane Lacaille^8,9,10, ¹Arthritis Research Centre of Canada, Richmind, BC, Canada, ²Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁵Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁶Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁷Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁸Arthritis Research Centre of Canada, Vancouver, BC, Canada, ⁹Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁰University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada
Background/Purpose: Comorbidities are increasingly recognized as significant contributors of decreased quality of life, and increased mortality in RA. RA is associated with an increased risk…
Abstract Number: 2307 • 2014 ACR/ARHP Annual Meeting
Cardiovascular Disease Prevention in Rheumatologic Disease: Assessing Screening in a Primary Care Setting
Micaela Bayard¹ and Magdalena Cadet², ¹Rheumatology, New York Hospital of Queens/ Weill Cornell Medical Center, New York, NY, ²Rheumatology and Immunology, Duke University School of Medicine, Durham, NC
Background/Purpose: To determine the proportion of patients diagnosed with rheumatologic disease receiving preventive health care according to US Preventive Services Task Force recommendations with emphasis…
Abstract Number: 2308 • 2014 ACR/ARHP Annual Meeting
Quality of Care for Cardiovascular Disease Prevention in RA: Compliance Lipid Screening Guidelines
Timothy J Schmidt^1,2, J Antonio Avina-Zubieta^3,4,5, Eric C. Sayre⁴, Michal Abrahamowicz⁶, John M. Esdaile^3,7,8 and Diane Lacaille^9,10,11, ¹Arthritis Research Centre of Canada, Richmind, BC, Canada, ²Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Richmond, BC, Canada, ³Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, ⁴Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁵Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁶Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁷Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁸Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁹Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁰Arthritis Research Centre of Canada, Vancouver, BC, Canada, ¹¹University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada
Background/Purpose: Comorbidities are increasingly recognized as significant contributors of reduced quality of life and increased mortality in RA. Cardiovascular diseases are the leading cause of…
Abstract Number: 2309 • 2014 ACR/ARHP Annual Meeting
A Novel Approach to Assess Wait-Times to Rheumatologists
Jessica Widdifield¹, Claire Bombardier², J. Carter Thorne³, R. Liisa Jaakkimainen⁴, J. Michael Paterson¹, Sasha Bernatsky⁵, Jacqueline Young¹, Laura Wing¹, Noah Ivers⁶, Debra Butt¹, Vivian Poon¹, Vandana Ahluwalia⁷ and Karen Tu¹, ¹Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto, ON, Canada, ³Southlake Regional Health Centre, Newmarket, Newmarket, ON, Canada, ⁴Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁵Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁶University of Toronto, Toronto, ON, Canada, ⁷William Osler Health Center, Brampton, ON, Canada
Background/Purpose: Previous studies quantifying delays in assessment of patients by rheumatologists have studied patients from rheumatology clinics and thus include all patients who ultimately had…
Abstract Number: 2310 • 2014 ACR/ARHP Annual Meeting
Improving Access to Health Care in Rheumatology Practices through Initiation of an Outpatient Urgent Care Clinic, a Paradigm Shift
Ruchi Jain, Meenakshi Jolly, Theodore Pincus, Isabel Castrejón, Annie Huang and Joel A. Block, Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Urgent care clinics are built into some primary care practices, but no reports are available of urgent care clinics in rheumatology settings. Many rheumatologists…
Abstract Number: 2311 • 2014 ACR/ARHP Annual Meeting
Tele-Rheumatology: Despite Improved Access Could There be a Potential Delay in Care without a Skilled “Presenter”?
Zsolt Kulcsar¹, Daniel A. Albert², Krista Merrihew³ and John Mecchella⁴, ¹Rheumatology/Leadership Preventive Medicine Residency, Dartmouth Hitchcock Medical Center, lebanon, NH, ²Rheumatology, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, ³Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ⁴Rheumatology, Giesel school of medicine and Dartmouth Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Arthritis treatment in New Hampshire (NH) is complicated by the fact that a large proportion of the population lives in rural areas (60%) with…
Abstract Number: 2272 • 2014 ACR/ARHP Annual Meeting
Assessment of Transition Readiness in Adolescents and Young Adults with Rheumatic and Other Chronic Health Conditions
Gabrielle Paul¹, Stephanie LaCount², Charles H. Spencer³, Gloria C. Higgins⁴, Karla Jones⁵, Brendan Boyle⁶, Manmohan K. Kamboj⁷, Christopher Smallwood⁸ and Stacy P. Ardoin⁹, ¹College of Medicine, Ohio State University, Columbus, OH, ²Pediatrics, Ohio State University, Columbus, OH, ³Rheumatology, Nationwide Childrens Hospital, Columbus, OH, ⁴Pediatric Rheumatology Ohio State University, Nationwide Childrens Hosp, Columbus, OH, ⁵Pediatrics, Nationwide Children's Hospital, Ohio, OH, ⁶Gastroenterology, Nationwide Children's Hospital, Columbus, OH, ⁷Endocrinology, Nationwide Children's Hospital, Columbus, OH, ⁸Family Medicine, Ohio State Univeristy, Columbus, OH, ⁹Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH
Background/Purpose The transition from pediatric to adult care is a vulnerable period. The lack of objective measures of transition readiness is a barrier to improving…
Abstract Number: 2273 • 2014 ACR/ARHP Annual Meeting
Does a Standardized Multidisciplinary Approach Improve Outcomes for Children with NMDA Receptor Antibody Encephalitis? : A Preliminary Assessment of a Single Center Experience
Mered Parnes¹, Amber Stocco², Trung Nguyen³, Jun Teruya⁴, Jeanine Graf³ and Eyal Muscal⁵, ¹Child Neurology, Baylor College of Medicine, Houston, TX, ²Integris Pediatric Neurology, Oklahoma City, OK, ³Pediatrics-critical care, Baylor College of Medicine, Houston, TX, ⁴Pathology, Baylor College of Medicine, Houston, TX, ⁵Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, TX
Background/Purpose: NMDA receptor antibody encephalitis (NMDAR) is a potentially devastating isolated autoimmune condition affecting children and young adults that was mostly unrecognized prior to 2007.…
Abstract Number: 2274 • 2014 ACR/ARHP Annual Meeting
TNF Inhibitors Provide Long-Term Clinical Benefits in 6 Patients with Early-Onset Sarcoidosis
Tomokazu Nagakura¹, Tsuyoshi Yamatou², Tomohiro Kubota², Hiroyuki Wakiguchi², Yuichi Yamasaki², Yukiko Nonaka², Tomoko Takezaki², Harumi Akaike², Yasuhito Nerome², Hiroyuki Imanaka² and Syuji Takei³, ¹Department of Pediatrics, House of Meguminoseibo, Usuki, Japan, ²Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan, ³School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Background/Purpose: Early-onset sarcoidosis (EOS) is a NOD2 gene-associated chronic autoinflammatory disease, characterized by the triad of arthritis, rash, and uveitis, which usually occurs in children…
Abstract Number: 2275 • 2014 ACR/ARHP Annual Meeting
Immunization Status and Barriers in Childhood Rheumatic Diseases
Shine Vazhappilly¹, Otto Vanderkooi^2,3,4, Susanne Benseler^3,5, Tommy Gerschman⁶, Nicole Johnson⁵, Nadia Luca⁵, Paivi Miettunen^3,7, Dwaraka Veeramreddy⁸ and Heinrike Schmeling^3,5, ¹University of Calgary, Calgary, AB, Canada, ²Pediatrics/Alberta Children's Hospital;, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, ³Alberta Children's Hospital Research Institute/University of Calgary, Calgary, AB, Canada, ⁴Pathology and Laboratory Medincine & Microbiology Immunology & Infectious Diseases, Department of Pathology and Laboratory Medicine & Microbiology Immunology & Infectious Diseases/University of Calgary, Calgary, AB, Canada, ⁵Pediatrics/Alberta Children's Hospital, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, ⁶Alberta Children's Hospital, Calgary, AB, Canada, ⁷Department of Pediatrics/Alberta Children's Hospital, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, ⁸Department of Pediatrics/Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada
Background/Purpose To determine the vaccination status of children with rheumatic diseases, and identify immunization knowledge of families and potential barriers to vaccination. Methods A cross-sectional…
Abstract Number: 2276 • 2014 ACR/ARHP Annual Meeting
Consensus Statement on the Transition Process from Pediatric Care to Adult Care in Patients with Chronic Inflammatory Rheumatic Diseases with Childhood-Onset
Maria Inmaculada Calvo-Penedes¹, Jordi Anton Lopez², Sagrario Bustabad-Reyes³, Marisol Camacho⁴, Jaime De Inocencio⁵, Maria Luz Gamir Gamir⁶, Genaro Graña⁷, Lucía La Cruz⁸, Juan Carlos Lopez-Robledillo⁹, Marta Medrano¹⁰, Rosa Merino¹¹, Consuelo Modesto¹², Esmeralda Nuñez¹³, Maria Jesus Rua Elorduy¹⁴, Vicente Torrente¹⁵, Carmen Vargas-Lebrón¹⁶ and Estibaliz Loza¹⁷, ¹Avda. Campanar, 21, H. de la Fe, Valencia, Spain, ²pediatric Rheumatology, University Childrenxs Hospital, Barcelona, Spain, ³Rheumatology, Hospital Universitario de Canarias, La Laguna, Spain, ⁴Hospital Universitario Virgen del Rocío, Sevilla, Spain, ⁵Hospital 12 de Octubre, Madrid, Spain, ⁶Hospital Universitario Ramón y Cajal, Madrid, Spain, ⁷Rheumatology, Complejo Hospitalario Universitario A Coruña, La Coruña, Spain, ⁸Hospital Universitari Son Dureta, Mallorca, Spain, ⁹Hospital Niño Jesus, Madrid, Spain, ¹⁰Rheumatology, Hospital Universitario Miguel Servet, Zaragoza, Spain, ¹¹Hospital Universitario La Paz, Madrid, Spain, ¹²Hospital Valle de Hebron, Barcelona, Spain, ¹³Hospital Regional Universitario Carlos Haya, Málaga, Spain, ¹⁴Pediatric Rheumatology, Hospital de Cruces, Barakaldo, Spain, ¹⁵Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain, ¹⁶Rheumatology, Hospital Virgen Macarena, Seville, Spain, ¹⁷Institu, Madrid, Spain
Background/Purpose: many young people with childhood-onset diseases, including rheumatic diseases, continue to require medical care into adult life. There are many differences between pediatric and…
Abstract Number: 2277 • 2014 ACR/ARHP Annual Meeting
Inpatient Pediatric Rheumatic Diseases: Characteristics, Cost and Trends
Monica Mahajan¹, Mohammad Shah², Mary Toth^3,4, Neil McNinch⁵ and Moussa El-Hallak⁶, ¹Department of Pediatrics, Akron Children's Hospital, Akron, OH, ²Patient Safety and Quality Services, Akron Children's Hospital, Akron, OH, ³Akron Children's Hospital, Akron, OH, ⁴Rheumatology, Akron Children's Hospital, Akron, OH, ⁵Rebecca D. Considine Research Institute, Akron Children's Hospital, Akron, OH, ⁶Dept of Pediatric Rheumatology, Akron Children's Hospital, Akron, OH
Background/Purpose: Childhood rheumatic diseases (cRD) have wide spectrum of complexity and disease course from mild disease to acute fulminate disease and even sudden death. Physicians…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].